The Global Health Body Issues Warning Over Severe Scarcity of Weight-Loss Medications

Fewer than 10% of people who could benefit from weight-loss injections such as Wegovy are able to get them, states the World Health Organization as it issues its initial guidance on the medications.

With in excess of 1,000,000,000 individuals worldwide currently classified as obese, it is urging broader and more equitable access to this class of drugs.

Per projections, more than two billion will be obese by 2030 without intervention.

"The new guidance acknowledges that excess weight is a lifelong illness that can be addressed with comprehensive and continuous treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.

High costs, insufficient output, and distribution challenges are key hurdles to universal access to the jabs that can assist patients in reducing considerable weight, explains the organization.

Skinny Jab Scarcity

Even in the current most optimistic scenario, the manufacturing of such drugs could only cover around 100 million people – fewer than 10% of those who need them, per the health organization.

The advice urges governments and firms to increase availability, by measures like voluntary licensing.

Exclusive production rights on semaglutide – the core component of a leading brand – is scheduled to end in multiple nations in 2026.

The Way Weight-Loss Injections Function

The injections imitate a body's own hormone to delay gastric emptying, curb appetite and increase feelings of fullness so people eat less.

Patients typically begin shedding pounds within a few weeks of commencing the regular doses.

Evidence suggests people may regain a significant portion within a year of stopping the drug, as their normal appetite come back.

Being overweight or obese elevates your risk for developing medical conditions, including diabetes, cardiovascular issues, brain attack, and certain cancers.

Excess weight affects people in countries worldwide and was associated with over three and a half million deaths worldwide in 2024, as per the WHO.